Funding Awarded to Improve Treatment Access for Opioid Use Disorder

Boston University Chobanian & Avedisian School of Medicine has been awarded funding by the Patient-Centered Outcomes Research Institute (PCORI). The funding award will support a study, “Comparing treatment use, retention, and patient outcomes pre- and post-implementation of federal policy changes regulating buprenorphine and methadone treatment for opioid use disorder,” led by Nicholas A. Livingston, PhD, […]

U.S. Medical Students, Residents Receive Limited Training on Treating Current and Formerly Incarcerated

Nearly 2 million Americans currently reside in jails or prisons, and another 4 million are involved in the criminal legal system under forms of community supervision such as parole and probation. There is a link between incarceration and chronic health issues; and the population involved in the U.S. justice system faces significant chronic health conditions, […]

New Study a First Step in Understanding Current Practice Patterns of Treatment for Sarcoidosis

Sarcoidosis is a multi-systemic disease of unknown etiology with a clinical presentation ranging from asymptomatic disease to organ failure. While some patients with sarcoidosis have spontaneous disease remission, others may require treatment for symptom management, organ involvement, and/or risk reduction of disease progression. Data on sarcoidosis treatment in the U.S. is limited and inconsistent, with […]

Diagnosing and Managing Blast Injuries

The prevalence of armed conflicts, terrorist attacks and industrial accidents necessitates clinician understanding of blast injuries in both civilian and military settings. Blast injuries are a complex form of trauma, resulting from the explosive release of energy. The severity and types of injury depend on the proximity to the blast, blast pressure and the presence […]

Atrial Fibrillation: A Review

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant complications associated with this condition include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia and mortality. In a new review article […]

Hui Feng, MD, PhD, Awarded NIH Grant to Further the Understanding of Neuroblastoma

Hui Feng, MD, PhD, associate professor of pharmacology, physiology & biophysics and medicine, has received an RO1 grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke. The five-year, $3.1M award will support the project, “Mechanisms of Immunosuppression in MYCN-driven Neuroblastoma.” Feng will team with Derin Keskin, PhD, from the Dana-Farber […]